Rocket Pharmaceuticals, Inc.

RCKT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$75,948$32,819$49,810$163,635
Short-Term Investments$146,810$238,675$268,354$208,701
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,922$5,661$6,329$5,847
Total Curr. Assets$227,680$277,155$324,493$378,183
Property Plant & Equip (Net)$74,169$77,640$80,393$83,322
Goodwill$39,154$39,154$39,154$39,154
Intangibles$25,150$25,150$25,150$25,150
Long-Term Investments$1,365$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$515$1,880$1,876$1,891
Total NC Assets$140,353$143,824$146,573$149,517
Other Assets$0$0$0$0
Total Assets$368,033$420,979$471,066$527,700
Liabilities
Payables$0$1,709$2,945$1,625
Short-Term Debt$2,912$2,894$2,876$2,857
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$28,258$38,796$29,490$36,202
Total Curr. Liab.$31,170$43,399$35,311$40,684
LT Debt$22,133$22,308$22,476$22,641
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,061$1,061$1,141$1,141
Total NC Liab.$23,194$23,369$23,617$23,782
Other Liabilities$0$0$0$0
Cap. Leases$22,133$25,202$25,352$25,498
Total Liabilities$54,364$66,768$58,928$64,466
Equity
Pref Stock$0$0$0$0
Common Stock$1,082$1,079$1,068$1,065
Retained Earnings-$1,398,701-$1,348,369-$1,279,450-$1,218,116
AOCI-$9-$107-$27$66
Other Equity$1,711,297$1,701,608$1,690,547$1,680,219
Total Equity$313,669$354,211$412,138$463,234
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$368,033$420,979$471,066$527,700
Net Debt-$50,903-$7,617-$24,458-$138,137
Rocket Pharmaceuticals, Inc. (RCKT) Financial Statements & Key Stats | AlphaPilot